The Chairman of the Board of Directors of Kenya BioVax Institute, Dr. Charles Githinji, today conducted a site visit to the Embakasi Facility to assess the ongoing enabling works and overall site preparedness. Accompanied by senior management and technical teams, Dr. Githinji

African media outlets can play a pivotal role in advancing vaccine independence by humanizing the story—profiling local scientists, manufacturers and communities to foster emotional connection, reduce skepticism, and build trust in locally made vaccines. This article from

Today, Kenya BioVax Institute 🇰🇪 participated in the official opening of the #BRITES Programme Stakeholder Planning Meeting, hosted by the Kenya Institute of Primate Research (Kenya Institute of Primate Research - KIPRE ). This two-day forum brings together a diverse network of public and private

Kenya BioVax Institute 🇰🇪 was glad to join the Moroccan Delegation sessions hosted by Africa Health Business (Africa Health Business), exploring East Africa’s pharma landscape and regulatory practices across 🇰🇪 Kenya, 🇺🇬 Uganda & 🇪🇹 Ethiopia. Valuable cross-border insights reaffirmed our

The Kenya BioVax Institute Management Team, in collaboration with the Board of Directors, is currently participating in the Mid-Term Review of the Strategic Plan, taking place from 5th to 8th August 2025 at Lake Naivasha Resort. This retreat provides an opportunity to reflect on

Juhudi Za Kuzalisha Chanjo Nchini Kenya inalenga kuzalisha chanjo zake ifikapo 2027 kupitia taasisi ya serikali ya BioVax. Matayarisho yamekuwa yakiendelea huko Naivasha #NTVAdhuhuri Sycilia Wakesho

Juhudi Za Kuzalisha Chanjo Nchini: Kwa miaka miwili ijayo Kenya itawasilisha chanjo za watoto kutoka shirika la Biovax, linalomilikiwa na serikali. Mradi huu wa serikali unalenga kuzalisha chanjo zaidi ya milioni tano na bidhaa nyingine. #NTVJioni Lofty Matambo Brygettes Ngana

BioVax Champions Local Manufacturing & UHC at #DevolutionConference2025 🇰🇪💉 Kenya BioVax Institute showcased its commitment to local vaccine manufacturing and Universal Health Coverage (UHC) during the national dialogue on devolution in Homa Bay County. Under the theme “For the

Strengthening Vaccine Security in a Changing Climate – BioVax Joins Global Health Dialogue The 4th Annual Daystar University Scientific Conference, held from 13th–15th August 2025 under the theme “Climate Change for Planetary Health,” brought together leading experts,

Acting CEO Dr. Cecilia Wanjala thanked the BioVax Board for backing our participation in #DevolutionConference2025, enabling us to showcase progress made in local vaccine manufacturing & partnerships with counties towards #UHC and #Vision2030. #BioVaxLeadership

At the 15th Best Practices Forum of the East, Central and Southern Africa Health Community ( ECSA-HC ), Dr.Rabera Kenyanya , Head of Technical Operations at Kenya BioVax, presented the long history of manufacturing in Africa, tracing its roots to 1930 in Kenya. Speaking under

Stakeholders in Mavoko Sub-County convened for an engagement forum aimed at strengthening immunization efforts in the region. The meeting, organized by the Ministry of Health through the National Vaccines and Immunization Program (NVIP) with support from PATH, provided a

🤝 Kenya BioVax stands with Ministry of Health, NVIP & PATH in strengthening immunization efforts in Mavoko. Together, we can boost vaccine uptake, safeguard communities & build a healthier Kenya. 💉🇰🇪 #VaccinesWork #ImmunizationForAll #StrongerTogether

Ministry of Health, Vision 2030 Leadership Rally Support for Kenya BioVax Mandate The Permanent Secretary of the State Department for Medical Services at the Ministry of Health, Dr. Ouma Oluga (Dr. Ouma Oluga, OGW), paid a courtesy call to the Kenya BioVax Institute. During the visit, he held